Loading stock data...

Denis Chem Lab Limited

BSE: DENISCHEM

BSE
75.02 -1.18 (-1.55%)

Prev Close

76.2

Open Price

75.4

Volume

2,895

Today Low / High

73.3 / 75.93

52 WK Low / High

72.35 / 124

Range

71 - 79

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 75.02, reflecting a change of -1.18 (-1.54856%). The expected target range on the BSE is 71 - 79. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 75.40 -0.50%
24 Feb 76.79 -0.77%
23 Feb 75.35 1.91%
20 Feb 79.50 0.24%
19 Feb 82.00 -1.43%
18 Feb 81.35 0.45%
17 Feb 83.00 -1.49%
16 Feb 79.30 4.09%
13 Feb 78.80 -2.20%
12 Feb 80.10 -3.60%
11 Feb 79.89 -1.13%
10 Feb 77.00 1.51%
09 Feb 79.00 -2.47%
06 Feb 78.00 -1.28%
05 Feb 78.69 -0.29%
04 Feb 79.00 -3.27%
03 Feb 79.49 -3.32%
02 Feb 79.00 -3.61%
01 Feb 81.78 -4.15%
30 Jan 77.00 1.29%
29 Jan 79.90 -4.37%
28 Jan 79.05 -3.93%

Denis Chem Lab Limited Graph

Denis Chem Lab Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Denis Chem Lab Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 75.02, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 75.02 75.77 68.19 - 83.35
76.52 61.22 - 91.82
77.27 54.09 - 100.45
Bearish Scenario 75.02 74.27 66.84 - 81.70
73.52 58.82 - 88.22
72.77 50.94 - 94.60

Overview of Denis Chem Lab Limited

ISIN

INE051G01012

Industry

Medical - Pharmaceuticals

Vol.Avg

4,569

Market Cap

1,041,027,633

Last Dividend

1.5

Official Website

Visit Website

IPO Date

2014-02-24

DCF Diff

-45.32

DCF

121

Financial Ratios Every Investor Needs

Stock Dividend of DENISCHEM

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 1.5 1.5 2025-09-19 2025-10-26
2024-09-19 September 19, 24 2.5 2.5 2024-09-19 2024-10-26
2023-09-22 September 22, 23 2 2 2023-09-22 2023-10-29
2022-09-20 September 20, 22 1.5 1.5 2022-09-21 2022-10-28
2021-09-20 September 20, 21 0.75 0.75 2021-09-21 2021-10-28

Stock Rating Details for DENISCHEM

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 173.30 Cr 117.89 Cr 55.41 Cr 0.3197 0.00 Cr 0.00 Cr 9.25 Cr 8.08 Cr 5.82 18.48 Cr 0.0466
2024-03-31 167.82 Cr 108.20 Cr 59.62 Cr 0.3553 0.00 Cr 0.00 Cr 14.29 Cr 11.16 Cr 8.04 22.48 Cr 0.0665
2023-03-31 160.81 Cr 86.61 Cr 39.98 Cr 0.2486 0.00 Cr 1.36 Cr 11.09 Cr 7.86 Cr 5.66 19.37 Cr 0.0489
2022-03-31 136.49 Cr 74.22 Cr 62.27 Cr 0.4562 0.00 Cr 1.13 Cr 11.66 Cr 6.26 Cr 4.51 15.40 Cr 0.0459
2021-03-31 109.14 Cr 57.30 Cr 51.85 Cr 0.4750 0.00 Cr 1.30 Cr 7.65 Cr 2.26 Cr 1.63 10.60 Cr 0.0207

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.18 Cr 112.27 Cr 27.17 Cr 85.1042 Cr 0.82 Cr -25.41 Cr 9.81 Cr 38.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 26.1725 Cr
2024-03-31 1.19 Cr 109.35 Cr 28.98 Cr 80.3665 Cr 0.59 Cr -0.60 Cr 10.19 Cr 38.35 Cr 0.17 Cr 0.00 Cr -23.33 Cr 27.1955 Cr
2023-03-31 2.48 Cr 99.45 Cr 27.18 Cr 72.2631 Cr 1.93 Cr -0.55 Cr 9.12 Cr 38.32 Cr 0.46 Cr 0.00 Cr -12.88 Cr 24.0751 Cr
2022-03-31 1.30 Cr 96.39 Cr 29.94 Cr 66.4513 Cr 3.22 Cr 1.92 Cr 9.89 Cr 41.38 Cr 0.35 Cr 0.60 Cr -5.60 Cr 25.3054 Cr
2021-03-31 1.57 Cr 92.26 Cr 30.76 Cr 61.5046 Cr 8.62 Cr 7.05 Cr 9.11 Cr 41.86 Cr 0.75 Cr 1.33 Cr 0.46 Cr 25.0967 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 12.4073 Cr -9.0555 Cr -3.6948 Cr 4.7789 Cr 24.4741 Cr 26.2337 Cr -7.6284 Cr 8.0758 Cr -0.2256 Cr -3.4692 Cr 0.3809 Cr
2024-03-31 18.3353 Cr -15.9583 Cr -3.6630 Cr 11.4075 Cr -1.2860 Cr 1.1933 Cr 0.0000 Cr 11.1558 Cr -0.8876 Cr -2.7753 Cr -1.0659 Cr
2023-03-31 16.3396 Cr -11.1545 Cr -4.0065 Cr 11.6435 Cr 1.1785 Cr 2.4796 Cr -4.6961 Cr 10.9158 Cr -1.2839 Cr -2.0814 Cr 0.7667 Cr
2022-03-31 17.0703 Cr -10.1378 Cr -7.2009 Cr 11.5798 Cr -0.2686 Cr 1.3011 Cr -5.4905 Cr 8.8834 Cr -5.4038 Cr -1.0408 Cr -0.7840 Cr
2021-03-31 7.9675 Cr -1.1293 Cr -5.5070 Cr 6.1316 Cr 1.3312 Cr 1.5697 Cr -1.8359 Cr 3.0872 Cr -3.9535 Cr 0.0000 Cr -0.5727 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 45.52 Cr 29.16 Cr 16.36 Cr 0.3593 4.19 Cr 3.32 Cr 2.39 6.02 Cr 0.0730
2025-09-30 46.17 Cr 30.39 Cr 15.79 Cr 0.3419 2.61 Cr 2.21 Cr 1.60 4.91 Cr 0.0479
2025-06-30 43.28 Cr 24.57 Cr 18.71 Cr 0.4324 3.20 Cr 2.48 Cr 1.78 5.11 Cr 0.0572
2025-03-31 41.38 Cr 28.20 Cr 13.19 Cr 0.3187 0.32 Cr 0.71 Cr 0.51 3.23 Cr 0.0171
2024-12-31 42.84 Cr 23.50 Cr 19.34 Cr 0.4515 1.99 Cr 1.76 Cr 1.27 4.12 Cr 0.0411

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 27.26 Cr 0.00 Cr 27.26 Cr 42.10 Cr 9.46 Cr 82.06 Cr 39.05 Cr 123.74 Cr 35.99 Cr
2025-03-31 26.23 Cr 0.00 Cr 26.23 Cr 30.61 Cr 9.81 Cr 70.64 Cr 38.79 Cr 112.27 Cr 27.17 Cr
2024-09-30 2.72 Cr 26.25 Cr 28.97 Cr 37.09 Cr 9.59 Cr 77.67 Cr 36.41 Cr 117.51 Cr 35.05 Cr
2024-03-31 1.19 Cr 24.60 Cr 25.80 Cr 33.00 Cr 10.19 Cr 69.37 Cr 38.35 Cr 109.35 Cr 28.98 Cr
2023-09-30 1.97 Cr 24.52 Cr 26.49 Cr 34.48 Cr 8.98 Cr 71.49 Cr 37.12 Cr 110.71 Cr 35.89 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 3.20 Cr 3.69 Cr 0.00 Cr 0.00 Cr 3.69 Cr 29.70 Cr 26.02 Cr 0.00 Cr 3.69 Cr
2023-09-30 2.54 Cr 2.54 Cr 0.00 Cr 0.00 Cr 2.54 Cr 26.02 Cr 23.47 Cr 0.00 Cr 2.54 Cr
2023-06-30 2.68 Cr 2.68 Cr 0.00 Cr 0.00 Cr -0.33 Cr 2.68 Cr 3.02 Cr 0.00 Cr 2.68 Cr
2023-03-31 0.78 Cr 0.78 Cr 0.00 Cr 0.00 Cr 0.78 Cr 3.02 Cr 2.24 Cr 0.00 Cr 0.78 Cr
2022-12-31 1.83 Cr 1.83 Cr 0.00 Cr 0.00 Cr -10.84 Cr 1.83 Cr 12.67 Cr 0.00 Cr 1.83 Cr

Splits History

Date Label Split Ratio
2017-09-07 September 07, 17 211:200
2014-03-27 March 27, 14 1019:500

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

MD & Executive Director
Himanshu Chaitanya Patel

Gender: Not Specified

Year Born: 1954

Chief Executive Officer
Nirmal Himanshu Patel

Gender: male

Year Born: 1986

Manager of Sales and Purchases
Sanjay Sanghvi

Gender: male

Year Born: 1964

Chief Finance Officer
Vikram Ramesh Joshi

Gender: male

Year Born: 1987

Compliance Officer & Company Secretary
Khushbu H. Shah

Gender: female

Year Born: 1987

FAQs about Denis Chem Lab Limited

Who is the CEO of the company?

The CEO is Nirmal Himanshu Patel.

What is the current market price of the stock?

The current price is ₹75.02.

What is the 52-week price range?

The range is ₹72.35-124.

What is the market capitalization of the company?

The market capitalization is ₹104.10 crores.

What is the dividend yield?

The dividend yield is 2.00%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 11.94.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Denis Chem Lab Limited (ISIN: INE051G01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹104.10 crores and an average daily volume of 4,569 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.5.